LINCOLN NATIONAL CORP - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
LINCOLN NATIONAL CORP ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$497,000
+13.5%
11,426
+13.5%
0.01%
+33.3%
Q1 2022$438,000
+14.4%
10,068
+15.9%
0.01%
+12.5%
Q4 2021$383,000
+29.4%
8,684
+12.1%
0.01%
+14.3%
Q3 2021$296,000
-11.6%
7,750
-7.9%
0.01%0.0%
Q2 2021$335,000
+18.0%
8,411
+5.5%
0.01%0.0%
Q1 2021$284,000
-13.9%
7,969
-11.2%
0.01%
-22.2%
Q4 2020$330,000
-30.2%
8,978
-28.6%
0.01%
-35.7%
Q3 2020$473,000
-8.5%
12,571
-0.9%
0.01%
-17.6%
Q2 2020$517,000
+41.3%
12,682
+31.3%
0.02%
+21.4%
Q1 2020$366,000
-18.5%
9,658
+1.1%
0.01%
-6.7%
Q4 2019$449,000
+38.6%
9,552
+25.8%
0.02%
+25.0%
Q3 2019$324,000
+5.9%
7,593
-0.8%
0.01%0.0%
Q2 2019$306,000
-0.6%
7,656
+3.9%
0.01%
-7.7%
Q1 2019$308,000
+4.8%
7,367
-4.2%
0.01%
-7.1%
Q4 2018$294,000
-10.4%
7,691
-5.9%
0.01%
+27.3%
Q3 2018$328,000
-1.8%
8,169
-1.6%
0.01%
-8.3%
Q2 2018$334,000
-3.2%
8,304
-6.0%
0.01%
-7.7%
Q1 2018$345,000
-24.5%
8,832
-31.6%
0.01%
-7.1%
Q4 2017$457,000
+97.8%
12,907
+127.4%
0.01%
+40.0%
Q3 2017$231,000
-4.5%
5,675
+0.9%
0.01%
-9.1%
Q2 2017$242,000
-5.1%
5,624
-5.0%
0.01%
-21.4%
Q3 2016$255,000
+22.6%
5,917
+23.1%
0.01%
+16.7%
Q2 2016$208,0004,8070.01%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2020
NameSharesValueWeighting ↓
JTC Employer Solutions Trustee Ltd 6,324,319$241,621,00032.36%
Black Creek Investment Management Inc. 10,329,349$394,684,00011.46%
Healthcare Value Capital, LLC 100,000$3,821,0007.54%
KAHN BROTHERS GROUP INC 1,353,358$51,711,809,0007.28%
EQUITY INVESTMENT CORP 2,924,326$111,738,0004.28%
Eversept Partners, LP 1,503,700$57,456,3773.99%
NKCFO LLC 269,500$10,298,0003.45%
Robinson Value Management, Ltd. 96,990$3,706,0003.31%
Keystone Financial Planning, Inc. 237,691$9,082,0003.30%
CLIFFORD CAPITAL PARTNERS LLC 93,485$3,572,0003.27%
View complete list of GLAXOSMITHKLINE PLC shareholders